Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
DataMeds AI entered an exclusive agreement licensing U.S. direct-to-consumer rights to Reboot Health AI's care management platform for GLP-1 patients. The platform will be integrated into the Health Lives Here app through monthly subscriptions, with revenue shared between the companies. The license covers intellectual
DataMeds AI entered an exclusive licensing, revenue-sharing and marketing agreement with Reboot Health AI for U.S. direct-to-consumer rights to its care-management platform. The partners plan to integrate Reboot’s technology into the Health Lives Here app for patients taking GLP-1 medications. Weight-management support